Ana is a molecular biologist with a passion for discovery and communication. As a science writer, she looks for connecting the public, in particular patients and healthcare providers, with clear and quality information about the latest medical advances. Ana holds a Ph.D. in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in infectious diseases, epigenetics, and gene expression.
Treatment with infliximab helps normalize the gut microbiome, soothing Crohn’s disease in children and adolescents, a study suggests. Longer studies are needed to understand if these medicines can fully ... Read more
A new artificial intelligence (AI) algorithm evaluates colonoscopy exams with a level of accuracy equivalent to experts, scientists in Japan report. The AI algorithm they developed may also help ... Read more
Delayed-release oral tablets of brilacidin for ulcerative colitis (UC) was found delivered and dispersed into the colon, and was well-tolerated in healthy volunteers in a Phase 1 trial, announced ... Read more
Arena Pharmaceuticals announced full long-term results of its OASIS extension study, confirming that once-daily oral etrasimod leads to sustained clinical responses and favorable safety for up to 46 weeks ... Read more
Provention Bio has completed patient enrollment for a Phase 2a clinical trial evaluating the efficacy and safety of its investigational oral therapy — PRV-6527 — for moderate to severe ... Read more